<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384758</url>
  </required_header>
  <id_info>
    <org_study_id>Perfusion under Compression</org_study_id>
    <nct_id>NCT03384758</nct_id>
  </id_info>
  <brief_title>Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus</brief_title>
  <official_title>Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Erlangen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Erlangen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy
      on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes
      Mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy
      on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes
      Mellitus. The microcirculation should be assessed by a combination of laserdoppler flowmetry
      and white light tissue spectrometry (O2C Device, Parameters sO2, Flow, rHb). By this, it is
      possible to detect the influence of the compression therapy on the skin microcirculation.

      Therefore, three study arms should be investigated, all patients clinically suffering under
      leg edema: healthy volunteers, patients with mild to moderate PAD and diabetics. All patients
      are recieveing compression therapy (Compression stockings class I for three hours, after a
      short break compression stockings class II for 3 hours) under Perfusion assessment control
      (O2C device).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by questionnaire</measure>
    <time_frame>12 Months</time_frame>
    <description>The Adverse Events are defined in the questionnaire as: Abort of the Therapy, Pressure marks, Quantification of the wearing comfort (Points 1-10), subjective reduction of the leg edema (Points 1-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sO2</measure>
    <time_frame>12 Months</time_frame>
    <description>The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter sO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flow</measure>
    <time_frame>12 Months</time_frame>
    <description>The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter Flow</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rHb</measure>
    <time_frame>12 Months</time_frame>
    <description>The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter rHb</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Leg Edema</condition>
  <arm_group>
    <arm_group_label>mild to moderate PAD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetes mellitus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Compression Therapy</intervention_name>
    <description>Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.</description>
    <arm_group_label>mild to moderate PAD</arm_group_label>
    <arm_group_label>Diabetes mellitus</arm_group_label>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Study-Arm PAD:

          -  leg edema

          -  symptomatic PAD (Fontaine stage II)

          -  no palpable foot pulses

          -  ABI &lt;0.9 and &gt;0.6, absolute ankle pressure &gt; 60mmHg

        Study-Arm Diabetes:

          -  leg edema

          -  Diabetes mellitus Typ 2 (history of longer than 2 years)

          -  palpable foot pulses

          -  Pallaesthesie &gt;6

          -  Wagner Score 0

        Exclusion Criteria:

        Study-Arm PAD:

          -  Critical limb ischemia

          -  ABI &lt; 0.6

          -  simoultaneous Diabetes Mellitus

        Study-Arm Diabetes:

          -  Wagner Score &gt;0

          -  Pallasthesie &lt;6
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ulrich Rother, PI</last_name>
    <phone>+4991318532968</phone>
    <email>ulrich.rother@uk-erlangen.de</email>
  </overall_contact>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2017</study_first_posted>
  <last_update_submitted>December 19, 2017</last_update_submitted>
  <last_update_submitted_qc>December 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Erlangen</investigator_affiliation>
    <investigator_full_name>Ulrich Rother</investigator_full_name>
    <investigator_title>Dr. med. Ulrich Rother</investigator_title>
  </responsible_party>
  <keyword>Compression therapy</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Diabetes mellitus</keyword>
  <keyword>Peripheral Arterial Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

